Evidence map›Paper›PMID 35342454›Full record

ArticleNano today2022

A comparison of Remdesivir versus gold cluster in COVID-19 animal model: A better therapeutic outcome of gold cluster.

Zhesheng He, Fei Ye, Chunyu Zhang, Jiadong Fan, Zhongying Du, Wencong Zhao, Qing Yuan, Wenchao Niu, Fuping Gao, Bo He and 13 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Nano today, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Structural and Mechanistic Characterization ofInternational journal of molecular sciences · 2026
    Article
  3. Review
  4. Review
  5. Article
  6. Ultrasmall PtAuTheranostics · 2023
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Zhesheng HeInstitute of High Energy Physics, Chinese Academy of Sciences, Beijing 100049, PR China.
Fei YeKey Laboratory of Biosafety, National Health and Family Planning Commission, National Institute for Viral Disease Control and Prevention, China CDC, Beijing 102206, PR China.
Chunyu ZhangDepartment of Life Science and Chemistry, Beijing University of Technology, Ping Le Yuan 100, Beijing 100124, PR China.
Jiadong FanShool of Physical Science and Technology, ShanghaiTech University, Shanghai 201210, PR China.
Zhongying DuDepartment of Life Science and Chemistry, Beijing University of Technology, Ping Le Yuan 100, Beijing 100124, PR China.
Wencong ZhaoDepartment of Life Science and Chemistry, Beijing University of Technology, Ping Le Yuan 100, Beijing 100124, PR China.
Qing YuanDepartment of Life Science and Chemistry, Beijing University of Technology, Ping Le Yuan 100, Beijing 100124, PR China.
Wenchao NiuDepartment of Life Science and Chemistry, Beijing University of Technology, Ping Le Yuan 100, Beijing 100124, PR China.
Fuping GaoInstitute of High Energy Physics, Chinese Academy of Sciences, Beijing 100049, PR China.
Bo HeShool of Physical Science and Technology, ShanghaiTech University, Shanghai 201210, PR China.
Peng CaoDepartment of Life Science and Chemistry, Beijing University of Technology, Ping Le Yuan 100, Beijing 100124, PR China.
Lina ZhaoInstitute of High Energy Physics, Chinese Academy of Sciences, Beijing 100049, PR China.
Xuejiao GaoCollege of Chemistry and Chemical Engineering, Jiangxi Normal University, Nanchang 330022, PR China.
Xingfa GaoCollege of Chemistry and Chemical Engineering, Jiangxi Normal University, Nanchang 330022, PR China.
Bo SunShanghai Advanced Research Institute, Chinese Academy of Sciences, No.239 Zhangheng Road, Shanghai 201204, PR China.
Yuhui DongInstitute of High Energy Physics, Chinese Academy of Sciences, Beijing 100049, PR China.
Jincun ZhaoState Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, First Affiliated Hospital of Guangzhou Medical University, Guangzhou, PR China.
Jianxun QiCAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing 100101, PR China.
Xing-Jie LiangCAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology, Beijing 100190, PR China.
Huaidong JiangShool of Physical Science and Technology, ShanghaiTech University, Shanghai 201210, PR China.
Yong GongInstitute of High Energy Physics, Chinese Academy of Sciences, Beijing 100049, PR China.
Wenjie TanKey Laboratory of Biosafety, National Health and Family Planning Commission, National Institute for Viral Disease Control and Prevention, China CDC, Beijing 102206, PR China.
Xueyun GaoDepartment of Life Science and Chemistry, Beijing University of Technology, Ping Le Yuan 100, Beijing 100124, PR China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

While gold compound have been approved for Rheumatoid arthritis treatment as it well suppresses inflammatory cytokines of patients, no such treatment is currently available for COVID-19 treatment

Indexed as

COVID-19Gold clusterInflammatory cytokineSARS-CoV-2Viral replication

Identifiers

PMID35342454
PMCPMC8934715

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.